The latest price target for Biomea Fusion (NASDAQ:BMEA) was reported by HC Wainwright & Co. on November 21, 2024. The analyst firm set a price target for $40.00 expecting BMEA to rise to within 12 months (a possible 553.59% upside). 34 analyst firms have reported ratings in the last year.

The latest analyst rating for Biomea Fusion (NASDAQ:BMEA) was provided by HC Wainwright & Co., and Biomea Fusion reiterated their buy rating.

The last upgrade for Biomea Fusion Inc happened on September 27, 2024 when Truist Securities raised their price target to $54. Truist Securities previously had a hold for Biomea Fusion Inc.

The last downgrade for Biomea Fusion Inc happened on June 11, 2024 when Truist Securities changed their price target from N/A to N/A for Biomea Fusion Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biomea Fusion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biomea Fusion was filed on November 21, 2024 so you should expect the next rating to be made available sometime around November 21, 2025.

While ratings are subjective and will change, the latest Biomea Fusion (BMEA) rating was a reiterated with a price target of $40.00 to $40.00. The current price Biomea Fusion (BMEA) is trading at is $6.12, which is out of the analyst’s predicted range.